Suppr超能文献

miRNA-204-5p:一种关键的肿瘤抑制因子。

MicroRNA-204-5p: A pivotal tumor suppressor.

机构信息

Wuxi Cancer Institute, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, China.

Laboratory of Cancer Epigenetics, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.

出版信息

Cancer Med. 2023 Feb;12(3):3185-3200. doi: 10.1002/cam4.5077. Epub 2022 Jul 31.

Abstract

MicroRNAs (miRNAs) are a class of non-coding single-stranded RNA molecules with a length of approximately 18-25 nt nucleotides that regulate gene expression post-transcriptionally. MiR-204-5p originates from the sixth intron of the transient receptor potential cation channel subfamily M member 3 (TRPM3) gene. MiR-204-5p is frequently downregulated in various cancer types and is related to the clinicopathological characteristics and prognosis of cancer patients. So far, many studies have determined that miR-204-5p functions as a tumor suppressor for its extensive and powerful capacity to inhibit tumor proliferation, metastasis, autophagy, and chemoresistance in multiple cancer types. MiR-204-5p appears to be a promising prognostic biomarker and a therapeutic target for human cancers. This review summarized the latest advances on the role of miR-204-5p in human cancers.

摘要

微小 RNA(miRNAs)是一类约 18-25nt 核苷酸长的非编码单链 RNA 分子,通过转录后调控基因表达。miR-204-5p 来源于瞬时受体电位阳离子通道亚家族 M 成员 3(TRPM3)基因的第六内含子。miR-204-5p 在多种癌症类型中经常下调,与癌症患者的临床病理特征和预后相关。到目前为止,许多研究已经确定 miR-204-5p 作为肿瘤抑制因子发挥作用,因为它具有广泛而强大的能力,可以抑制多种癌症类型中的肿瘤增殖、转移、自噬和化疗耐药性。miR-204-5p 似乎是一种很有前途的预后生物标志物和人类癌症的治疗靶点。本综述总结了 miR-204-5p 在人类癌症中的最新研究进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c81a/9939231/230ec6501cd9/CAM4-12-3185-g003.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验